Hitoshi Miyazawa

8.2k citations
39 papers · 1.9k indexed · h-index 18

Hitoshi Miyazawa

39 papers receiving 1.9k citations

Peers

Hitoshi Miyazawa
Comparison fields: 5 of 94
  • Pulmonary and Respiratory Medicine 1.3k
  • Oncology 1.0k
  • Cancer Research 412
  • Dermatology 135
  • Molecular Biology 540
Replace Hiroshi Ogawa with:
Hiroshi Ogawa Japan
G Tamura Japan
Davor Tomas Croatia
S Matsuno Japan
Isabel Ruiz‐Ávila Spain
Terufumi Kubo Japan
S. Simonetti Italy
Shuichi Kawashiri Japan
Truong D. Dang United States
Harumi Nakamura Japan
Hitoshi Miyazawa relative to Hiroshi Ogawa Japan Hiroshi Ogawa's profile →
Citations per field
00.5×1.5×2.4×
Hiroshi Ogawa · 1×
Citations per year

Countries citing papers authored by Hitoshi Miyazawa

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Miyazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Miyazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Miyazawa more than expected).

Fields of papers citing papers by Hitoshi Miyazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Miyazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Miyazawa. The network helps show where Hitoshi Miyazawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hitoshi Miyazawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hitoshi Miyazawa Line = papers co-authored together Hitoshi Miyazawa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20227
2
Factors Associated with Uremic Pruritus in Patients Undergoing Peritoneal Dialysis
20201
3 201710
4 201296
5 201174
6 20116
7 2009369
8 2009156
9 200872
10 200821
11 200818
12 200715
13 200745
14 200688
15 2006143
16 20013
17 199617
18 199516
19 19898
20 198811

About Hitoshi Miyazawa

Hitoshi Miyazawa is a scholar working on Dermatology, Immunology and Allergy and Developmental Biology, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Research Studies (5 papers), Immune Cell Function and Interaction (4 papers), Contact Dermatitis and Allergies (4 papers), Allergic Rhinitis and Sensitization (3 papers), Cancer Genomics and Diagnostics (3 papers) and Occupational exposure and asthma (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.3k citations), Oncology (1.0k citations) and Cancer Research (412 citations). Hitoshi Miyazawa has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Koichi Hagiwara, Tomoaki Tanaka, Kunihiko Kobayashi, Huqun, Kiyoshi Udagawa, Yoshiaki Nagai, Minoru Kanazawa, Kenji Ikebuchi, Motoyasu Kato and Akihiko Gemma. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026